Andreas Nikolaos Papadopoulos

Mr. Andreas Nikolaos Papadopoulos

Epidemiology and public health, National and Kapodistrian University of Athens, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Neurology Clinical Practice
Verified
Journal Article
Closed access
PDF file
EAEfthalia Angelopoulou
Efthalia Angelopoulou
Anastasia BougeaAnastasia Bougea
Anastasia Bougea
APAndreas Nikolaos Papadopoulos
Andreas Nikolaos Papadopoulos
Nikolaos PapagiannakisNikolaos Papagiannakis
Nikolaos Papagiannakis
ASAthina-Maria Simitsi
Athina-Maria Simitsi
LSLeonidas Stefanis
Leonidas Stefanis
Purpose of Review To evaluate whether CSF and circulating neurofilament light chain (NfL), a marker of axonal damage, could discriminate Parkinson disease (PD) from atypical parkinsonian syndromes (APSs). Recent Findings MEDLINE and Scopus were systematically searched, and 15 studies were included (1,035 patients with PD and 930 patients with APS). CSF NfL levels were 1.26 SDs higher in the APS group compared to the PD group (g = 1.26 [95% confidence interval 0.99–1.53]), and circulating NfL levels were 1.53 SDs higher in the APS group compared to the PD group (g = 1.53 [95% confidence interval 1.15–1.91]); 4 studies, 307 patients with PD, 197 patients with APS. Pooled areas under the curve were 0.941 (0.916–0.965) and 0.874 (0.802–0.946) for CSF and circulating NfL, corresponding to average sensitivities of 86% (79%–90%) and 91% (86%–95%), and specificity of 88% (82%–92%) and 76% (62%–85%), respectively. Summary These results strongly support the high diagnostic accuracy of both CSF and circulating NfL in differentiating PD from APS, highlighting their usefulness as promising biomarkers.

20 November 2022 in Medicina
Verified
Journal Article
Open access
PDF file
Efthalia AngelopoulouEfthalia Angelopoulou
Efthalia Angelopoulou
APAndreas Nikolaos Papadopoulos
Andreas Nikolaos Papadopoulos
NSNikolaos Spantideas
Nikolaos Spantideas
Anastasia BougeaAnastasia Bougea
Anastasia Bougea
Background and Objectives: The relationship between migraine and tension-type headache (TTH) with Parkinson’s disease (PD) is controversial, while a common pathophysiological link remains obscure. The aim of this systematic review is to investigate the association between PD, migraine and TTH. Materials and Methods: Following PRISMA, we searched MEDLINE, WebofScience, Scopus, CINAHL, Cochrane Library and ClinicalTrials.gov up to 1 July 2022 for observational studies examining the prevalence and/or associations of PD with migraine and TTH. We pooled proportions, standardized mean differences (SMD) and odds ratios (OR) with random effects models. The risk of bias was assessed with the Newcastle-Ottawa scale (PROSPERO CRD42021273238). Results: Out of 1031 screened studies, 12 were finally included in our review (median quality score 6/9). The prevalence of any headache among PD patients was estimated at 49.1% (760 PD patients; 95% CI 24.8–73.6), migraine prevalence at 17.2% (1242 PD patients; 95% CI 9.9–25.9), while 61.5% (316 PD patients; 95% CI 52.6–70.1) of PD patients with migraine reported headache improvement after PD onset. Overall, migraine was not associated with PD (302,165 individuals; ORpooled = 1.11; 95% CI 0.72–1.72).However, cohort studies demonstrated a positive association of PD among lifetime migraineurs (143,583 individuals; ORpooled = 1.54, 95% CI 1.28–1.84), while studies on 12-month migraine prevalence yielded an inverse association (5195 individuals; ORpooled = 0.64, 95% CI 0.43–0.97). Similar findings were reported by 3 studies with data on the TTH-PD relationship (high prevalence, positive association when examined prospectively and an inverse relationship on 12-month prevalence). These data were not quantitatively synthesized due to methodological differences among the studies. Finally, PD patients suffering from any headache had a lower motor unified Parkinson’s disease rating scale (UPDRS) score (503 PD patients; SMD −0.39; 95% CI −0.57 to −0.21) compared to PD patients not reporting headache. There is an unclear association of headaches in genetic PD cohorts. Conclusions: Observational data suggest that migraine and TTH could be linked to PD, but the current literature is conflicting.

29 March 2021 in medRxiv
Verified
Preprint
Open access
PDF file
APAndreas Nikolaos Papadopoulos
Andreas Nikolaos Papadopoulos
KPKonstantinos Palaiopanos
Konstantinos Palaiopanos
HBHarry Björkbacka
Harry Björkbacka
APAnnette Peters
Annette Peters
JLJames A. de Lemos
James A. de Lemos
Marios K GeorgakisMarios K Georgakis
Marios K Georgakis
Objective To determine the association between circulating interleukin-6 (IL-6) levels and risk of incident ischemic stroke in the general population. Methods Following the PRISMA guidelines, we systematically searched the literature for population-based prospective cohort studies exploring the association between circulating IL-6 levels and risk of incident ischemic stroke. We pooled association estimates for ischemic stroke risk with random-effect meta-analyses and explored non-linear effects in dose-response meta-analyses. Risk of bias was assessed with the Newcastle-Ottawa scale (NOS). Results We identified 11 studies (n=27,411 individuals; 2,669 incident stroke cases) meeting our eligibility criteria. Overall, quality of the included studies was high (median 8 out of 9 NOS points). In meta-analyses, 1-standard deviation increment in circulating IL-6 levels was associated with a 19% increase in risk of incident ischemic stroke over a mean follow-up of 12.4 years (RR 1.19; 95% CI 1.10 to 1.28). A dose-response meta-analysis showed a linear association between circulating IL-6 levels and ischemic stroke risk. There was only moderate heterogeneity and the results were consistent in sensitivity analyses restricted to studies of low risk of bias and studies fully adjusting for demographic and vascular risk factors. The results also remained stable following adjustment for publication bias. Conclusions Higher circulating IL-6 levels in community-dwelling individuals are associated with higher long-term risk of incident ischemic stroke in a linear pattern and independently of conventional vascular risk factors. Along with findings from genetic studies and clinical trials, these results provide additional support for a key role of IL-6 signaling in ischemic stroke.